|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.00 USD | +0.11% |
|
+3.21% | +3.23% |
| 21/01 | Morgan Stanley Adjusts Price Target on Exelon to $51 From $49, Maintains Equalweight Rating | MT |
| 21/01 | Barclays Adjusts Price Target on Exelon to $50 From $52, Maintains Overweight Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | $49.12 | +9.27% | 17 | ||||||
| $753.66 | +10.05% | 27 | ||||||
| $90.87 | +8.82% | 22 | ||||||
| €17.82 | -3.22% | 22 | ||||||
| $406.46 | +37.6% | 17 | ||||||
| €9.25 | +3.5% | 23 | ||||||
| $95.23 | +7.21% | 20 | ||||||
| $135 | +12.92% | 17 | ||||||
| $128.53 | +7.81% | 18 | ||||||
| $230.1 | +46.74% | 20 | ||||||
| $63.5 | +3.94% | 16 | ||||||
| $86.65 | +13.7% | 17 | ||||||
| $105.01 | +10.83% | 22 | ||||||
| $103.53 | -1.45% | 17 | ||||||
| GBX 24.76 | +6.65% | 15 | ||||||
| €28.14 | -6.6% | 23 | ||||||
| $120.62 | +10.6% | 17 | ||||||
| $21.2 | +39.02% | 15 | ||||||
| CZK 904.04 | -20.35% | 13 | ||||||
| $202.25 | +35.82% | 14 | ||||||
| Average | 178.79 | +11.64% | 19 | ||||||
| Weighted average by Cap. | 208.91 | +11.05% | 20 |
- Stock Market
- Equities
- EXC Stock
- Sector Exelon Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition